Oral complications of childhood cancer and its treatment: Current best practice

European Journal of Cancer

Volumn 40, Issue 7, 2004, Pages 1035-1041

  Belfield, P M ^a   Dwyer, A A ^a  

^a CHILDREN S HOSPITAL OF PHILADELPHIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; ALUMINUM MAGNESIUM HYDROXIDE; AMPHOTERICIN B; ANALGESIC AGENT; ANTACID AGENT; ANTIINFECTIVE AGENT; ANTIVIRUS AGENT; BENZYDAMINE; BLEOMYCIN; CASPOFUNGIN; CHLORHEXIDINE; CISPLATIN; CLOTRIMAZOLE; DIPHENHYDRAMINE; DYCLONINE; ETOPOSIDE; FAMCICLOVIR; FLUOROURACIL; FOSCARNET; GANCICLOVIR; GLUTAMINE; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; LIDOCAINE; METHOTREXATE; PILOCARPINE; POLYMYXIN; PYRROLE DERIVATIVE; SUCRALFATE; TOBRAMYCIN; UNINDEXED DRUG; VIVONEX;

CHILDHOOD CANCER; HUMAN; MOUTH HYGIENE; MUCOSA INFLAMMATION; MYCOSIS; NEPHROTOXICITY; PATHOPHYSIOLOGY; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVIEW; VIRUS INFECTION; XEROSTOMIA;

EID: 1942453256     PISSN: 09598049     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ejca.2003.09.041     Document Type: Article

References (45)

1. Leggot P. Oral complications in the pediatric population. NCI Monographs. 9:1990;129-131.
2. Simon A.R., Roberts M.W. Management of oral complications associated with cancer therapy in pediatric patients. J. Dent. Child. 1991;384-389.
3. Borbasi S., Cameron K., Quested B., Olver I., To B., Evans D. More than a sore mouth. patient's experience of oral mucositis Oncol. Nurs. Forum. 29:2002;1051-1057.
4. Dodd M., Miaskowski C., Greenspan D., Shis A., Facione N. Radiation-induced clinical trial of micronized sucralfate versus salt and soda mouthwashes. Cancer Invest. 21:2003;21-33.
5. Dunbar P.J., Buckley P., Gavrin J.R., Sanders J.S., Chapman C.R. Use of patient-controlled analgesia for pain control for children receiving bone marrow transplant. J. Pain Symptom Manage. 10:1995;604-611.
6. Collins J.J., Geake J., Grier H.E.et al. Patient-controlled analgesia for mucositis pain in children. a three-period crossover study comparing morphine and hydromorphone J. Pediatr. 129:1996;722-728.
7. Bonnaure-Mallet M., Bunetel S., Triscot-Doleux S.et al. Oral complications during treatment of malignant diseases in childhood. effects of tooth brushing Eur. J. Cancer. 34:1998;1588-1591.
8. Cheng K.K., Molassiotis A., Chang A.M., Wai W.C., Cheung S.S. Evaluation of an oral care protocol intervention in the prevention of chemotherapy-induced oral mucositis in paediatric cancer patients. Eur. J. Cancer. 37:2001;2056-2063.
9. Sonis S.T. Mucositis as a biological process. a new hypothesis for the development of chemotherapy-induced stomatotoxicity Oral Oncol. 34:1998;39-43.
10. Wilkes J.D. Prevention and treatment of oral mucositis following cancer chemotherapy. Seminars in Oncology. 25:1998;538-551.
11. Kostler W.J., Hejna M., Wentxel C., Zielinski C.C. Oral mucositis complicating chemotherapy and/or radiotherapy. options for prevention and treatment Cancer J. Clin. 51:2001;290-315.
12. Stockman M.A., Spijkervet F.K., Wymenga A.N.et al. Quantification of oral mucositis due to radiotherapy by determining viability and maturation of epithelial cells. J. Oral Pathol. Med. 31:2002;153-157.
13. World Health Organization handbook for reporting the results of cancer treatment. WHO Offset Publications. Geneva 1979; Series number 48 (Albany, N.Y.: sold by WHO Publications Center USA.
14. National Cancer Institute. Cancer Therapy Evaluation Program: Common toxicity Criteria. Version 2.0 June 1, 1999. http://ctep.cancer.gov/reporting/ ctc.html (accessed 3/7/03).
15. McGuire D.B., Peterson D.E., Muller S., Owen D.C., Slemmons M.F., Schubert M.M. The 20 item oral mucositis index. reliability and validity in bone marrow and stem cell transplant patients Cancer Invest. 20:2002;893-903.
16. Sonis S.T., Eilers J.P., Epstein J.B.et al. Validation of a new scoring system for the assessment of clinical trial research of oral mucositis induced by radiation or chemotherapy. Cancer. 85:1999;2103-2113.
17. Karthaus M., Rosenthal C., Ganser A. Prophylaxis and treatment of chemo-and radiotherapy-induced oral mucositis - are there new strategies? Bone Marrow Transplant. 24:1999;1095-1108.
18. Edelman M.J., Gandara D.R., Perez E.A.et al. Phase I trial of edatrexate plus carboplatin in metastatic non-small cell lung cancer. a southwest oncology group study Invest. New Drugs. 16:1998;69-75.
19. Gandara D.R., Edelman M.J., Crowley J.J., Lau D.H., Livingston R.B. Phase II trial of edatrexate plus carboplatin in metastatic non-small-cell lung cancer. a southwest oncology group study Cancer Chemo. Pharmacol. 41:1997;75-78.
20. Worthington H.V., Clarkson J.E. Prevention of oral mucositis and oral candidiasis for patients with cancer treated with chemotherapy. cochrane systematic review J. Dent. Educ. 66:2002;903-911.
21. Cengiz M., Ozyar E., Ozuturk D., Akyol F., Atahan I.L., Hayran M. Sucralfate in the prevention of radiation-induced oral mucositis. J. Clin. Gastrenerol. 28:1999;40-43.
22. Shih A., Miakowski C., Dodd M.J., Stotts N.A., MacPhail L. A research review of the current treatments for radiation-induced oral mucositis in patients with head and neck cancer. Oncol. Nurs. Forum. 29:2002;1063-1078.
23. Hejna M., Kostler W.J., Raderer M.et al. Decrease of duration and symptoms in chemotherapy-induced oral mucositis by topical GM-CSF. Eur. J. Cancer. 37:2001;1994-2002.
24. Anderson P.M., Schroeder G., Skubitz K.M. Oral glutamine reduces the duration and severity of stomatitis after cytotoxic cancer chemotherapy. Cancer. 83:1998;1433-1439.
25. Dodd M., Dibble S., Miaskowski C.et al. Randomized clinical trial of the effectiveness of 3 commonly used mouthwashes to treat chemotherapy-induced mucositis. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 90:2000;39-47.
26. Epstein J., Schubert M. Oral mucositis in myelosuppressive cancer therapy. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endo. 88:1999;272-276.
27. Kennedy L., Diamond J. Assessment and management of chemotherapy-induced mucositis in children. J. Pediatr. Oncol. Nurs. 14:1997;164-174.
28. Peitsch J.B., Ford C., Whitlock J.A. Nasogastric tube feedings in children with high-risk cancer. a pilot study J. Pediatr. Hemato. Oncol. 21:1999;111-114.
29. Carrega G., Castagnola E., Canessa A.et al. Herpes simplex virus and oral mucositis in children with cancer. Support Care Cancer. 2:1994;266-269.
30. Madeya M. Oral complications from cancer therapy. part I - pathophysiology and secondary complications Oncol. Nurs. Forum. 23:1996;801-807.
31. Epstein J.B., Chow A.W. Oral complications associated with immunosuppression and cancer therapies. Infect. Dis. Clin. North Am. 13:1999;901-923.
32. Glick M., Siegel M.A. Viral and fungal infections of the oral cavity in immunocompetent patients. Infect. Dis. Clin. North Am. 13:1999;817-831.
33. Rex J.H., Walsh T.J., Sobel J.D.et al. Practice guidelines for the treatment of Candidiasis. Clin. Infect. Dis. 30:2000;662-678.
34. Klingspor L., Stintzing G., Tollemar J. Deep candida infection in children with leukaemia. clinical presentations, diagnosis and outcome Acta Paediartic. 86:1997;30-35.
35. Levy-Polack M.P., Sebelli P., Polack N.L. Incidence of oral complications and application of a preventive protocol in children with acute leukemia. Spec. Care Dentistry. 18:1998;189-193.
36. Merck, Co., INC., Whitehouse Station, N.J. USA, Caspofungin acetate, Issued January 2003.
37. Haggood A.S. Head and neck cancers. Otto S.E. Oncol. Nurs. 4th edn:1991;285-325 Mosby, St. Louis MO.
38. Deutsh M. The use of pilocarpine hydrochloride to prevent xerostomia in a child treated with high dose radiotherapy for nasopharynx carcinoma. Oral. Oncol. 34:1998;381-382.
39. Leek H., Albertsson M. Pilocarpine treatment of xerostomia in head and neck patients. Micron. 33:2002;153-155.
40. Kaste S.C., Hopkins K.P., Jones D., Crom D., Greenwald C.A., Santana V.M. Dental abnormalities in children treated for acute lymphoblastic leukemia. Leukemia. 11:1997;792-796.
41. Kaste S.C., Hopkins K.P., Bowman L.C., Santana V.M. Dental Abnormalities in children treated for neuroblastoma. Med. Pediatr. Oncol. 30:1998;22-27.
42. Minicucci E.M., Lopex L.F., Crocci A.J. Dental abnormalities in children after chemotherapy treatment for acute lymphoid leukemia. Leuk. Res. 27:2003;45-50.
43. Estilo C.L., Huryn J.M., Kraus D.H.et al. Effects of therapy on dentofacial development in long-term survivors of head and neck rhabdomyosarcoma. the Memorial Sloan-Kettering cancer center experience J. Pediatr. Hematol. Oncol. 25:2003;215-222.
44. Rojas de Morales T., Zambrano O., Rivera L.et al. Oral-disease prevention in children with cancer. testing preventive protocol effectiveness Medicina Oral. 6:2001;326-334.
45. Larson P.J., Miaskowski C., MacPhail L.et al. The PRO-SELF mouth aware program. an effective approach for reducing chemotherapy-induced mucositis Cancer Nurs. 21:1998;263-268.